On May 18, 2023, Oncorus, Inc.'s board of directors appointed Alexander Nolte as the Company's principal accounting officer. Mr. Nolte, age 51, joins the Company from Syndax Pharmaceuticals, Inc., where he served in various roles within the company's finance department from 2017 to May 2023, most recently as its Vice President, Chief Accounting Officer. Prior to joining Syndax, Mr. Nolte served as Corporate Controller at CoLucid Pharmaceuticals, Inc. from 2015 to 2017, prior to its acquisition by Eli Lilly.

Earlier in his career, Mr. Nolte served as Director of Revenue Recognition and International Accounting at Aegerion Pharmaceuticals from 2013 to 2015, and prior to that he held several finance positions at Genzyme Corporation. Mr. Nolte began his professional career at KPMG Accountant NV in the Netherlands and PricewaterhouseCoopers LLP in Boston, Massachusetts. Mr. Nolte received his B.S. in Accountancy from The Hague University in 1996.

He is a Certified Public Accountant in the Commonwealth of Massachusetts.